The workflow
Exit and returns
Five scenarios on your cheque, and the exit it takes to return the fund.
The returns model answers the question scoring does not: if this company works, what does this cheque return? It is computed, with no model call anywhere in it, and the report labels it as computed.
What it computes
From the round terms it derives your ownership, then dilutes it round by round to exit. Five scenarios run from failure to a home run, each with a probability, and their weighted sum is the expected multiple.
Where the numbers come from
Probabilities start from published base rates, then adjust to the company’s own revenue and sector. Every base rate is cited next to the number it produced.
Your fund, your cheque
The model reads your fund size and cheque from your Fund DNA, so the exit it takes to return the fund is yours, not an industry average. Those economics stay on the fund’s copy: a report the company sees, or one shared outside the fund, is built without them.
Drug companies
For a drug company, the published odds of reaching approval from its current phase are shown beside the scenarios, with their source. They do not replace the model’s failure rates: drug companies are often licensed or bought before approval, and no published source ties approval odds to venture losses.